Loading the company…
Loading the company…
㈜바임
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-11-02 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Daejeon, founded in 2019. Industry: Bio & Pharma. Group consolidated revenue for 2025 was ₩126.2bn — this includes subsidiaries and is not the revenue of this entity alone. It has 199 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Unqualified”.
Loading…
Latest filing 2022-11-23 · latest registration 2026-06-24 · newest first
본 발명은 락트산계 중합체, 락트산계 중합체 및 폴리에틸렌글리콜을 함유하는 블록 공중합체 및 고분자 히알루론산을 포함하는 생분해성 고분자 분산체, 및 이의 제조방법에 관한 것으로서, 기능성 유효성분의 효과적인 담지가 가능할뿐만 아니라, 그 자체로도 피부에 침투 시 우수한 생리활성을 나타내고, 분산 안정성이 현저히 개선되어 조직으로의 우수한 전달 효과를 제공할 수 있다.
본 발명은 복합체, 이의 제조방법 및 이를 이용한 성형용 필러 조성물에 관한 것으로서, 상기 복합체는 입도분포(PSD)가 제어된 생분해성 입자; 및 수용성 고분자를 포함한다. 이러한 본 발명의 복합체는 장기보관성 및 분산성이 우수할 수 있다.
본 발명은 락트산계 중합체, 락트산계 중합체 및 폴리에틸렌글리콜을 함유하는 블록 공중합체(PEG-PLA) 및 히알루론산 혼합물을 포함하고, 그 자체로도 우수한 생리활성을 가지며, 상기 락트산계 중합체의 분산 안정성이 우수하며, 유효성분의 효과적인 담지가 가능한 생분해성 고분자 분산체에 관한 것이다. 또한, 상기 생분해성 고분자 분산체를 포함하는 조성물 및 피부 개선 시스템을 제공하는 것에 관한 것이다.
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 3 of 3 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 81.2 | 126.2 |
| Cost of sales | 8.4 | 12.7 |
| Gross profit (loss) | 72.9 | 113.5 |
| Selling, general and administrative expenses | 17.7 | 33.2 |
| Operating income (loss) | 55.1 | 80.4 |
| Non-operating income | 1.4 | 1.9 |
| Other gains | 0.1 | 0.0 |
| Finance income | 1.3 | 1.9 |
| Non-operating expenses | 2.0 | 1.6 |
| Other losses | 0.3 | 0.5 |
| Finance costs | 1.6 | 1.1 |
| Profit (loss) before tax | 54.6 | 80.7 |
| Income tax expense | 11.2 | 16.5 |
| Net income (loss) | 43.4 | 64.1 |
Revenue ₩126.2bn, up 55.3% YoY.
Operating margin 63.7% (prior 67.9%).
Net income ₩64.1bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.
Headlines and links to public articles only · not checked by us (original ↗) · articles are in Korean — English headlines are our translation; where none is shown, “Read in English ›” opens a machine translation · “Broker view” is a forecast, not reported results · checked 2026-11-05